Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

by Tessa Niemeyer‐van der Kolk, Hein van derWall, Geretta K. Hogendoorn, Rianne Rijneveld, Sascha Luijten, Dirk C.J.G. vanAlewijk, Ellen H.A. van denMunckhof, Marieke L. deKam, Gary L. Feiss, Errol P. Prens, Jacobus Burggraaf, Robert Rissmann, Martijn B.A. vanDoorn
Published 2020-09-01